Department of Pharmaceutical Sciences, College of Pharmacy & Health Sciences, St. John's University, Queens, NY 11439, USA.
Gustaf H. Carlson School of Chemistry & Biochemistry, Clark University, Worcester, MA 01610, USA.
Future Med Chem. 2024 Feb;16(3):239-251. doi: 10.4155/fmc-2023-0124. Epub 2024 Jan 11.
Gankyrin is an ankyrin-repeat protein that promotes cell proliferation, tumor development and cancer progression when overexpressed. To design and synthesize a novel series of gankyrin-binding small molecules predicated on a 2,5-pyrimidine scaffold. The synthesized compounds were evaluated for their antiproliferative activity, ability to bind gankyrin and effects on cell cycle progression and the proteasomal degradation pathway. Compounds and demonstrated the most potent antiproliferative activity against MCF7 and A549 cells, respectively. Both compounds also demonstrated the ability to effectively bind gankyrin, disrupt proteasomal degradation and inhibit cell cycle progression. The 2,5-pyrimidine scaffold exhibits a novel and promising strategy for binding gankyrin and inhibiting cancer cell proliferation.
Gankyrin 是一种锚蛋白重复蛋白,当过度表达时,可促进细胞增殖、肿瘤发展和癌症进展。设计并合成了一系列基于 2,5-嘧啶骨架的新型 Gankyrin 结合小分子。评估了合成化合物的抗增殖活性、与 Gankyrin 结合的能力以及对细胞周期进程和蛋白酶体降解途径的影响。化合物 和 分别对 MCF7 和 A549 细胞表现出最强的抗增殖活性。这两种化合物还都具有有效结合 Gankyrin、破坏蛋白酶体降解和抑制细胞周期进程的能力。2,5-嘧啶骨架为结合 Gankyrin 和抑制癌细胞增殖提供了一种新颖而有前途的策略。